Suzhou Highfine Biotech Co., Ltd. (SHE:301393)
China · Delayed Price · Currency is CNY 56.90
+0.20 (0.35%)
At close: Sep 3, 2026
Suzhou Highfine Biotech Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 711.19 | 602.26 | 451.87 | 388.79 | 447.46 | 369.44 |
Revenue Growth | 43.06% | 33.28% | 16.22% | -13.11% | 21.12% | 30.85% |
Gross Profit Gross Profit Growth | 228.63 | 203.15 | 179.36 | 145.36 | 192.78 | 171.47 |
Operating Income Operating Income Growth | 114.38 | 102.75 | 94.29 | 79.21 | 141.88 | 127.44 |
Net Income Net Income Growth | 109.51 | 114.65 | 134.05 | 98.97 | 129.37 | 111.4 |
Earnings Per Share EPS Growth | 1.02 | 1.07 | 1.24 | 1.07 | 1.60 | 1.38 |
EPS Growth | -23.24% | -13.68% | 15.79% | -33.13% | 15.94% | 176.00% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
China China Growth | 436 | 288.01 | 262.06 |
Export Export Growth | 166.26 | 163.87 | 126.73 |
Total Total Growth | 602.26 | 451.87 | 388.79 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,257 | 1,311 | 1,707 | 1,770 | 159.32 | 123.05 |
Total Debt Total Debt Growth | 119.67 | 51.33 | 3.28 | 1.56 | 1.43 | 2.2 |
Net Cash (Debt) Net Cash Growth | 1,138 | 1,259 | 1,704 | 1,769 | 157.9 | 120.85 |
Net Cash Growth | -32.94% | -26.10% | -3.66% | 1020.18% | 30.65% | 19.58% |
Net Cash Per Share Net Cash Per Share Growth | 10.60 | 11.75 | 15.75 | 19.12 | 1.95 | 1.50 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 159.52 | 77.67 | 126.37 | 87.83 | 138.67 | 75.97 |
Capital Expenditures CapEx Growth | -381.03 | -210.83 | -107.75 | -120.47 | -81.4 | -53.56 |
Free Cash Flow Free Cash Flow Growth | -221.51 | -133.16 | 18.62 | -32.64 | 57.27 | 22.42 |
Free Cash Flow Growth | - | - | - | - | 155.48% | 3.12% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | 32.15% | 33.73% | 39.69% | 37.39% | 43.08% | 46.41% |
Operating Margin | 16.08% | 17.06% | 20.87% | 20.37% | 31.71% | 34.50% |
Pretax Margin | 17.38% | 21.46% | 34.22% | 28.93% | 33.29% | 34.93% |
Profit Margin | 15.40% | 19.04% | 29.67% | 25.46% | 28.91% | 30.15% |
FCF Margin | -31.15% | -22.11% | 4.12% | -8.40% | 12.80% | 6.07% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.405 | 0.405 | 0.390 | 0.250 | 0.250 | 2.500 |
Dividend Per Share Growth | 3.85% | 3.85% | 56.00% | 0% | -90.00% | - |
Dividend Yield | 0.71% | 0.80% | 0.99% | 0.43% | - | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 55.78 | 47.30 | 31.85 | 65.48 | - | - |
Forward PE | - | 33.79 | 23.69 | 34.44 | - | - |
P/FCF Ratio | - | - | 229.29 | - | - | - |
PS Ratio | 8.58 | 9.00 | 9.45 | 16.67 | - | - |